Cited by 524Pancreatic and Hepatic Oncology ResearchMetabolism, Diabetes, and CancerPancreatitis Pathology and Treatment

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer

Open access

Andersen, Dana K., Korc, Murray, Petersen, Gloria M., Eibl, Guido, Li, Donghui, Rickels, Michael R., Chari, Suresh T., Abbruzzese, James L.·2017·Diabetes

DOI 10.2337/db16-1477PMC PMC5399609

Open this paper in CoChat — free account Open PDF

Abstract

The relationships between diabetes and pancreatic ductal adenocarcinoma (PDAC) are complex. Longstanding type 2 diabetes (T2DM) is a risk factor for pancreatic cancer, but increasing epidemiological data point to PDAC as also a cause of diabetes due to unknown mechanisms. New-onset diabetes is of particular interest to the oncology community as the differentiation of new-onset diabetes caused by PDAC as distinct from T2DM may allow for earlier diagnosis of PDAC. To address these relationships and raise awareness of the relationships between PDAC and diabetes, a symposium entitled Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer was held at the American Diabetes Association’s 76th Scientific Sessions in June 2016. This article summarizes the data presented at that symposium, describing the current understanding of the interrelationships between diabetes, diabetes management, and pancreatic cancer, and identifies areas where additional research is needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/db16-1477

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer statistics, 2016
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015) · JAMA · doi:10.1001/jama.2015.10029 · Cited by 2,362
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166 · cited 1×
“Concomitantly, there is failure to enhance peripheral (predominantly skeletal muscle) glucose utilization, with initially increased insulin levels, as the b-cell attempts to overcome the insulin resistance (9).”
Background
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
Wellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
The genetic architecture of type 2 diabetes
Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., Gaulton, K. J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D. J., et al. (2016) · Nature · doi:10.1038/nature18642 · Cited by 1,051
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 2×
“Susceptibility genes that have been identified range from rare mutations in genes associated with cancer syndromes to common SNPs. Designs that include familybased and case-control studies have uncovered mutations in known syndrome-related genes, such as BRCA1, BRCA2, CDKN2A, and CFTR. Next-generation sequencing has i…”
Background
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M. G., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 808

Flagged first, then by citations

Show all 50 references

Sorted by citations

Items 301–400 of 524

New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicenter study
Liu, P., Zhou, Z., Wang, G.-Y., Xu, S., Wang, W., Chen, X., Tan, X., Liu, Z.-H., Zhao, Z.-M., Gao, Y., et al. (2025) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2025.04.008 · Cited by 3
Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements
Jallod, I. M. S., Abbas, A. K., Yaqoob, F. I., & Aziz, A.-A. A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04209-5 · Cited by 3
Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes
Davidsen, L., Jensen, M. H., Kronborg, T., Hangaard, S., Vestergaard, P., Drewes, A. M., Knop, F. K., Cichosz, S. L., & Olesen, S. S. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251356239 · Cited by 6
Two decades of mortality trends in pancreatic cancer and diabetes mellitus: A retrospective cross-sectional study of the United States population (1999–2020)
Cheema, A. A. A., Shaikh, A., Kumari, N., Rafay, M. A., & Khan, A. (2025) · Medicine · doi:10.1097/md.0000000000046372 · Cited by 3
Pancreatic Cancer Screening in Patients with Type 2 Diabetes Mellitus: A Narrative Review
Danilă, M., Ghiuchici, A.-M., Bende, R., Rațiu, I., & Bende, F. (2025) · Medicina · doi:10.3390/medicina62010067 · Cited by 3
Endocrine and metabolic complications of advanced cancer
Ryan, R., & Casey, R. (2021) · doi:10.1093/med/9780198821328.003.0084 · Cited by 3
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System
Khalaf, N. I., Kramer, J. R., Liu, Y., Abrams, D., Singh, H., El‐Serag, H. B., & Kanwal, F. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08035-8 · Cited by 3
Exploring the Role of Hyperinsulinemia in Obesity-Associated Tumor Development
Vélez-Bonet, E., Gumpper, K., & Cruz‐Monserrate, Z. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-3932 · Cited by 3
Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer
Yang, Y., Liu, L., Cui, H., Cheng, B., Peng, W., Wang, R., Wang, J., Chen, W., Cao, M., Li, Y., et al. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae072 · Cited by 3
Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients
Kadaj-Lipka, R., & Rydzewska, G. M. (2020) · Gastroenterology Review · doi:10.5114/pg.2020.101556 · Cited by 3
Diabetes mellitus tipo 3c secundaria a pancreatitis crónica: reporte de un caso
Universidad César Vallejo, F. D. C. M. T., Deza, C. M. G., López, J. G. C., Universidad Nacional de Trujillo. Trujillo, P., Ríos, E. D. S. G., & Universidad César Vallejo, F. D. C. M. T. (2020) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2021.v21n1.12 · Cited by 3
A 3-Dimensional Coculture Model to Visualize and Monitor Interaction Between Pancreatic Cancer and Islet β Cells
Kumar, S., Jach, D., Macfarlane, W. M., & Crnogorac‐Jurcevic, T. (2021) · Pancreas · doi:10.1097/mpa.0000000000001865 · Cited by 3
Factors influencing mortality trends of pancreatic cancer in Spain, 1955-2020
Ortiz, E. G. (2022) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2022.8559/2021 · Cited by 3
Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer
Liang, Y., Chen, W., Tang, Y., & Chen, M. (2022) · Biochemical Genetics · doi:10.1007/s10528-022-10308-2 · Cited by 4
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment
Pretta, A., Ziranu, P., Giampieri, R., Donisi, C., Cimbro, E., Spanu, D., Lai, E., Pecci, F., Balconi, F., Lupi, A., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.11.012 · Cited by 3
Paneth Cell, Gut Microbiota Dysbiosis and Diabetes Mellitus
Luvhengo, T. E., Mabasa, S., Molepo, E., Taunyane, I., & Palweni, S. T. (2023) · Applied Sciences · doi:10.3390/app13116605 · Cited by 3
Pancreatogenic diabetes presenting with diabetic ketoacidosis: A rare manifestation of chronic pancreatitis
Shriwastav, U. K., Agarwal, M., Raina, R., & Kant, R. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1665_22 · Cited by 3
Diabetic keto-acidosis in pancreatic diabetes – how is it different from DKA in type 1 or type 2 DM?
Mondal, S., Dasgupta, R., Lodh, M., Parida, A. K., Haldar, M., & Ganguly, A. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01244-x · Cited by 3
New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular Subtype
Trembath, H. E., LaBella, M. E., Kearney, J. F., Hariharan, A., Zarmer, S., Nabors, M., McCabe, I. C., Zhao, R. T., Meyers, M. O., Kim, H. J., et al. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.28044 · Cited by 3
Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy
Zhao, X., Wang, Y., Zhou, L., Ye, A., & Zhu, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-85807-4 · Cited by 3
Accuracy and feasibility of continuous glucose monitoring system in pancreatectomy patients
Choi, Y. J., Jeon, S. M., Yu, S., Jo, H.-S., Kim, D., & Yu, Y. (2025) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-024-03601-8 · Cited by 3
Sporadic Pancreatic Cancer: Glucose Homeostasis and Pancreatogenic Type 3 Diabetes
Škrha, J., Fric, P., Bušek, P., Škrha, P., & Šedo, A. (2018) · InTech eBooks · doi:10.5772/intechopen.75740 · Cited by 3
MicroRNA-30b is involved in the pathological process of diabetes mellitus induced by pancreatic cancer by regulating plasminogen activator inhibitor-1
Yan, W., He, Z., Dong, J., Liu, C., Zuo, Z., & Liu, X. (2019) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2019.1698977 · Cited by 3
Оцінка прогнозованого ризику онкологічних захворювань у хворих на цукровий діабет 2-го типу
Вацеба, Т. С., SOKOLOVA, L. K., & Koshel, N. M. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.1.2021.226437 · Cited by 3
In Vivo Models for Obesity and Obesity Related Carcinogenesis
Dey, S. K., & Senapati, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-1846-8_14 · Cited by 3
Pancreatic Crosstalk in the Disease Setting: Understanding the Impact of Exocrine Disease on Endocrine Function
Villaca, C. B. P., & Mastracci, T. L. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230008 · Cited by 12
Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer
Sun, Y., Wan, H., Xiong, J., Cao, K., Yang, D., & Huang, J. X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1559909 · Cited by 3
Structural organizations of membrane lipids from human lung cancer and healthy cells
Gasymov, O. K., Bakhishova, M. J., Melikova, L. A., & Aliyev, J. A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144133 · Cited by 2
Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study
Koo, D., Jung, J., Han, K., & Park, C. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70205 · Cited by 2
New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions
Tao, L. V., Karasinska, J. M., Souza, V. G. P., Loree, J. M., Johnson, J. D., Renouf, D. J., & Schaeffer, D. F. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2025.1645459 · Cited by 3
Type 3c Diabetes Mellitus: Epidemiology, Diagnosis, Management, and Research Imperatives With Insights From the United Arab Emirates and Global Contexts
Lazar, M. V., Menon, A. C. S., & Thomas, J. P. (2026) · Cureus · doi:10.7759/cureus.105089 · Cited by 2
The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary Tract
Rahmani, B., Gandhi, J., Joshi, G. S., Smith, N. L., Reid, I., & Khan, S. A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200305094727 · Cited by 2
A Case Report of New-Onset Diabetes Mellitus as an Early Warning Sign of Pancreatic Ductal Adenocarcinoma in an Elderly Patient: The Earlier the Diagnosis and Surgery, the Better the Prognosis
Bertoni, M., Bertoni, C., Abatangelo, S., Scatizzi, M., & Lotti, P. (2022) · Cureus · doi:10.7759/cureus.31608 · Cited by 2
Nutrition in Pancreatic Cancer
Petzel, M. Q. B., & Ebrus, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_26 · Cited by 2
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians
Piccardi, M., Gentiluomo, M., Bertoncini, S., Pezzilli, R., Erőss, B. M., Bunduc, Ș., Uzunoglu, F. G., Talar‐Wojnarowska, R., Vanagas, T., Sperti, C., et al. (2023) · Biological Research · doi:10.1186/s40659-023-00457-y · Cited by 2
La diabetes tipo 3c. Abordaje desde el médico del primer nivel
Díaz, M. S., Unanua, M. P. P., Martínez, I. P., Serrano, A., & Rodríguez, J. C. A. (2023) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2023.102074 · Cited by 4
A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma
Wu, Z., Liu, C., Ma, Z., Li, Z., Wang, S., Chen, Y., Han, M., Huang, S., Zhou, Q., Zhang, C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21642 · Cited by 2
Le cancer du pancréas est un fardeau préoccupant à l’échelle mondiale
Ferlay, J., & Partensky, C. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30076-8 · Cited by 2
Screening for pancreatic ductal adenocarcinoma in the population with diabetes
Sharp, P. S., Brown, B., & Price, H. C. (2021) · Practical Diabetes · doi:10.1002/pdi.2319 · Cited by 2
Fatty Pancreas: An Underappreciated Intersection of the Metabolic Profile and Pancreatic Adenocarcinoma
Swislocki, A. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0070 · Cited by 2
Recomendaciones para el diagnóstico y tratamiento del adenocarcinoma ductal de páncreas
Pasqua, A. V., Moro, M., Alle, L., Basso, S., Canicoba, M., Capitanich, P., Carballido, M., Cayol, F., Crisci, J., Fernández, D., et al. (2020) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/xaqm8690 · Cited by 2
Phytonutrients in the management of glucose metabolism
Ullah, H., & Daglia, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824356-5.00011-4 · Cited by 2
Current trends in the diagnosis of pancreatic cancer
Vaněk, P., Eid, M., Psár, R., Zoundjiekpon, V., Urban, O., & Kunovský, L. (2022) · Vnitřní lékařství · doi:10.36290/vnl.2022.076 · Cited by 2
Molecular epidemiology and biology of pancreatic cancer among Iranian patients: an updated preliminary review
Kichi, Z. A., Rezaei, Z., Soltani, M., & Shirvani-Farsani, Z. (2022) · Advances in Translational Medicine · doi:10.55976/atm.120221391-16 · Cited by 2
The Evaluation of Gallstone Disease in the Year Before Pancreatic Cancer Diagnosis
Papageorge, M. V., de Geus, S. W. L., Woods, A. P., Ng, S. C., McAneny, D. B., Tseng, J. F., Kenzik, K. M., & Sachs, T. E. (2023) · Journal of Surgical Research · doi:10.1016/j.jss.2023.06.017 · Cited by 2
Simulating the healthcare workforce impact and capacity for pancreatic cancer care in Victoria: a model-based analysis
Gao, L., Ugalde, A., Livingston, P. M., WHITE, V. M., Watts, J. J., Jongebloed, H., McCaffrey, N., Menzies, D., & Robinson, S. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10722-9 · Cited by 2
Factors affecting weight management in overweight or obese diabetic patients: the 2018-2021 Korea national health and nutrition examination survey
Yeun, Y.-R., Kwak, Y., & Kim, H.-Y. (2024) · Physical Activity and Nutrition · doi:10.20463/pan.2024.0004 · Cited by 2
Ductal Adenocarcinoma
Campbell, F., & Verbeke, C. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-49848-1_9 · Cited by 2
The Role of Diabetes Mellitus in the Malignant Pancreatic Cyst Neoplasm Diagnosis and Prognosis
Deng, J., Guo, Y., Gu, J., Du, J., Kong, L., Tao, B., Li, J., & Fu, D. (2022) · Cancer Management and Research · doi:10.2147/cmar.s355365 · Cited by 2
Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the development and validation of a clinical prediction model (QPancreasD)Preprint
Tan, P. S., Clift, A. K., Liao, W., Patone, M., Coupland, C. A. C., Bashford-Rogers, R. J. M., Sivakumar, S., Clifton, D. A., Pereira, S. P., & Hippisley‐Cox, J. (2021) · medRxiv · doi:10.1101/2021.12.22.21268161 · Cited by 2
Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake
Abecassis, A., Hermano, E., Yifrach, A., Popovtzer, A., Meirovitz, A., & Elkin, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1287084 · Cited by 1
A Recent Overview of the Growing Applications of Biosimilars in Pancreatic Cancer Management: Current Picture and Future Perspectives
Gupta, D., Gupta, D. S., & Shetty, S. R. (2024) · Springer eBooks · doi:10.1007/978-981-97-3001-8_9 · Cited by 1
Updates in the Management of Chronic Pancreatitis
Vaněk, P., & Freeman, M. L. (2024) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2024.08.008 · Cited by 1
Development of Potential Pharmacological Targets to Normalize Gene Expression in Islets of Type 2 Diabetic Patients
Basaldúa-Maciel, V., Martínez–Esquivias, F., & Guzmán‐Flores, J. M. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673352470250312082922 · Cited by 1
Metabolic syndrome as a prognostic factor in advanced pancreatic cancer: a predictive model and chemotherapy evaluation
Zhang, J., Li, J., Deng, H., Zhao, Y., & Zhang, Y. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03940-w · Cited by 1
Global burden of colorectal cancer attributable to high fasting plasma glucose from 1990 to 2021 and projection to 2040
Li, Y., Hong, W., Chen, P., & Zhang, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1590382 · Cited by 1
Diabetes and pancreatic cancer: a complex and confounding interplay
Chari, S. T. (2025) · Gut · doi:10.1136/gutjnl-2025-336806 · Cited by 1
Self-citation
Asia’s accelerating burden of early-onset pancreatic cancer: a 32-year global comparative analysis using GBD 2021
Ye, X., Jiang, M., Chen, S., Yang, J., Shi, Y., Zhao, M., Li, H., Bao, Y., Wang, W., Du, S. Y., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003864 · Cited by 1
Persistence of severe global inequalities in the burden of pancreatic cancer: a cross-sectional study
Qing, X., Liu, Y., & Xia, C. (2026) · Discover Oncology · doi:10.1007/s12672-025-04380-4 · Cited by 1
Redefining pancreatogenic diabetes mellitus through molecular, imaging, and AI-driven evidence
Rangraze, I. R., El‐Tanani, M., Wali, A. F., Babiker, R., Rabbani, S. A., Matalka, I. I., Satyam, S. M., Арманович, А. А., Hoffmann, K., Ilias, I., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1749805 · Cited by 3
Impaired insulin secretion via the Wnt5a/β-catenin pathway contributes to diabetes development in pancreatic cancer
Lee, M., Park, H. S., Kim, H. S., Choi, A., Nahm, J. H., Lim, B. J., Park, J. S., Ahn, C. W., Ko, Y., Yoon, D. S., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01625-8 · Cited by 1
Continuous Glucose Monitoring to Compare Glycemic Patterns and Variability in Insulin-Treated Pancreatic Diabetes Mellitus with Type 1 Diabetes and a Clue to the Influence of Pancreatic Enzyme Replacement
Goswami, S., Gaikwad, P. M., Mondal, S., Chowdhury, A. S., Das, N., Palui, R., Mandal, S., Baidya, A., & Sengupta, N. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702251406273 · Cited by 1
Involvement of Adrenomedullin Expression in Tumor Cells and Stroma in the Development of Diabetes in Pancreatic Cancer Patients
Hideyuki, I. M. A. I., Ohike, N., Norose, T., Isobe, T., Fujimasa, K., Nagahama, M., Tanaka, J., Nagasaka, S., & Takimoto, M. (2018) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.30.341 · Cited by 1
Insulin Resistance Is a Common Core Tethered to Diabetes and Pancreatic Cancer Risk
Verma, H. K., & Bhaskar, L. V. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_12 · Cited by 1
Exploring prior diseases associated with pancreatic cancer
Lee, C. T., Hu, J.-X., & Liu, C.-M. (2021) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2021.100707 · Cited by 1
Laparoscopic Whipple
Kunzler, F., & Asbun, H. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-67940-8_15 · Cited by 1
Pancreatic cancer, pancreatogenic diabetes, type 2 diabetes mellitus
Друк, И. В. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-205-9-171-182 · Cited by 1
Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2023)
Kaser, S., Hofer, S. E., Kazemi-Shirazi, L., Festa, A., Winhofer, Y., Sourij, H., Brath, H., Riedl, M., Resl, M., Clodi, M., et al. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02123-x · Cited by 2
Gene Expression Comparison between Alcohol-Exposed versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis
Doronzo, A., Porcelli, L., Marziliano, D., Inglese, G., Argentiero, A., Azzariti, A., & Solimando, A. G. (2023) · Medicina · doi:10.3390/medicina59050872 · Cited by 1
Hyperglycemia Effects on Blood Pressure in Adults: A Systematic Review and Meta-Analysis
Asmara, H. S., Ja'afar, N. L., Wan‐Arfah, N., & Meramat, A. A. (2023) · Asian Journal of Medicine and Biomedicine · doi:10.37231/ajmb.2023.1.s.665 · Cited by 1
Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease
Stålberg, S. M., Silwal‐Pandit, L., Bastani, N. E., Nebdal, D. J. H., Lingjærde, O. C., Skålhegg, B. S., & Kure, E. H. (2024) · BMC Cancer · doi:10.1186/s12885-024-12320-8 · Cited by 1
Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study
Zhang, J., He, J., Lu, Y., & Lan, T. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1498207 · Cited by 1
Unusual Manifestations of Primary Pancreatic Neoplasia
Włoszek, E., Krupa, K., Fudalej, M. M., Miski, H., Badowska-Kozakiewicz, A. M., & Deptała, A. (2025) · Cancers · doi:10.3390/cancers17193240 · Cited by 1
Cancer Exosomes for Early Pancreatic Cancer Diagnosis and Role in Metastasis
Korc, M., & McElyea, S. D. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_67 · Cited by 1
Self-citation
Screening for Pancreatic Cancer in Individuals With New-onset Diabetes Mellitus
Lo, T. (2018) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2018.07.010 · Cited by 1
Diabetes mellitus asociada a pancreatitis autoinmune: Caso clínico
Esteban Pinto, K., Cecilia Vargas, R., Patricia Gómez, G., Pilar Durruty, A., & Gloria López, S. (2019) · Revista médica de Chile · doi:10.4067/s0034-98872019000500668 · Cited by 1
ДОСЛІДЖЕННЯ МЕХАНІЗМІВ ОНКОЛОГІЧНОГО РИЗИКУ У ХВОРИХ З ЦУКРОВИМ ДІАБЕТОМ 2 ТИПУ.
Вацеба, Т. С., & SOKOLOVA, L. K. (2020) · Art of Medicine · doi:10.21802/artm.2019.4.12.44 · Cited by 1
Management of Pancreatic Exocrine Insufficiency
Powell-Brett, S. F., Chinuck, R. S., & Roberts, K. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_43 · Cited by 1
Clinical characteristics of endocrinopathies in Chinese patients with hereditary haemochromatosis
Wu, H., Yu, M., Xiao, C., Zhang, Q., & Xiao, X. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3448 · Cited by 1
Review of Diabetes Mellitus in Relation to Pancreatic Cancer
(2021) · doi:10.31038/cmcrr.2021111 · Cited by 1
Cancer Exosomes for Early Pancreatic Cancer Diagnosis and Role in Metastasis
Korc, M., & McElyea, S. D. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_67-1 · Cited by 1
Self-citation
Epigenetics of PNLIPRP1 in human pancreas reveals a molecular path between type 2 diabetes and pancreatic cancerPreprint
Maurin, L., Marselli, L., Ning, L., Boissel, M., Boutry, R., Suleiman, M., Leloire, A., Pascat, V., Maina, J. G., Toussaint, B., et al. (2022) · medRxiv · doi:10.1101/2022.12.30.22284058 · Cited by 2
Inhibition of adipose tissue-derived fatty acid binding protein suppresses pancreatic cancer progression and metastasisPreprint
Shinoda, S., Nakamura, N., Inoko, K., Sato‐Dahlman, M., Carmella, S., Hecht, S. S., Bernlohr, D., Ikramuddin, S., & Yamamoto, M. (2024) · Research Square · doi:10.21203/rs.3.rs-5404541/v1 · Cited by 1
Escherichia-Shigella expansion and metabolite dysregulation in type 3c diabetesPreprint
Soto, E. K., Wagner, V., Engl, J., Mederer, M., Cibulkova, V., Piater, J., Schäfer, B., Dunzendorfer, E., Waschina, S., Kaser, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.02.691786 · Cited by 1
Hemoglobina glicosilada como signo de alarma
Martín-Regidor, M., Bonache-Castejón, N., Fernández-Pérez, M. E., Martínez-Alonso, A., & Sancho-Pascual, G. (2019) · Revista Española de Casos Clínicos en Medicina Interna · doi:10.32818/reccmi.a4s1a5
Efecto de ácidos grasos poliinsaturados y ácido nordihidroguaiarético sobre alteraciones pancreáticas en un modelo experimental de diabetes mellitus tipo 2
Díaz-Gerevini, G. T., Terceros, J., López, C. B., Poggio, L., Daín, A., & Repossi, G. (2019) · Alad · doi:10.24875/alad.19000372
Loss of TIP30 Accelerates Pancreatic Cancer Progression and Metastasis
Williams, I., & Imade, E. (2019)
Diabetes with Pancreatic Ductal Adenocarcinoma
Srivani, G., Dariya, B., Alam, A., & Nagaraju, G. P. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_7
Diagnosis and Therapy Particularities in Post-Cholecystectomy Cholangitis at Patients with Type 2 Diabetes Mellitus
Ungur, M., Pop, A.-L., Maghiar, A. M., Mircea Teodor, P. O. P., Feder, B., & Babeş, A. (2019) · Internal Medicine · doi:10.2478/inmed-2019-0081
Changes in Pancreatic Endocrine Function and Morphology After Pancreaticoduodenectomy
Yoon, H. J., Choi, J. S., Shin, W. Y., Lee, K.-Y., & Ahn, S. (2020) · Pancreas · doi:10.1097/mpa.0000000000001492
Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for Protein Biomarkers
Oldfield, L. S., Barrera, L. N., Williams, D., Evans, A., Neoptolemos, J. P., & Costello, E. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_4
Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones?
Subham, K., Mohanty, S., Jena, S., Ojha, M., & Jha, S. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-5471-1_13
INSULIN RESISTANCE IN PATIENTS WITH PANCREATIC AND COLORECTAL CANCER DIAGNOSED AGAINST THE BACKGROUND OF TYPE 2 DIABETES MELLITUS
Вацеба, Т. С. (2021) · Art of Medicine · doi:10.21802/artm.2020.4.16.21
On the Origin of Morphological Structures of Planetary Nebulae
Kwok, S. (2011) · The HKU Scholars Hub (University of Hong Kong)
Editorial: Introduction to the issue: chronic pancreatitis, diabetes and pancreatic cancer consortium (CPDPC)
Yadav, D. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000771
Islet Inflammation: The Link between Type 2 Diabetes and Pancreatic Cancer
Mukhuty, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98538
Undetected Pancreatic Adenocarcinoma on CT: Frequency According to CT Scan ProtocolPreprint
Iarovich, M. D., Apter, S., Konen, E., Inbar, Y., Amitai, M. M., & Klang, E. (2021) · Research Square · doi:10.21203/rs.3.rs-737370/v1
Current Approaches in Chronic Pancreatitis
Saka, D., Boynukara, C., Cadircibasi, E. R., & Şışman, G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98214
ISG20L2 as a Novel Prognostic Biomarker Facilitates the Progression of Pancreatic Cancer via GlycolysisPreprint
Wei, J., Gao, X., Ren, B., Sun, D., & Liu, T. (2021) · Research Square · doi:10.21203/rs.3.rs-900506/v1
Perioperative glycemic and nutritional management of 32 patients undergoing total pancreatectomy
Sasanuma, H., Sata, N., Shimodaira, K., Aoki, Y., Meguro, Y., Miyato, H., Morishima, K., Miki, A., Endo, K., Koizumi, M., et al. (2021) · Suizo · doi:10.2958/suizo.36.351

Authors: Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L.
Affiliations: National Institutes of Health (US)
Indiana University Indianapolis (US)
Mayo Clinic (US)
University of California, Los Angeles (US)
The University of Texas MD Anderson Cancer Center (US)
University of Pennsylvania (US)
Duke University (US)
Corresponding author: Abbruzzese, James L.
ORCID: Andersen, Dana K.
Korc, Murray
Petersen, Gloria M.
Eibl, Guido
Li, Donghui
Rickels, Michael R.
Chari, Suresh T.
Abbruzzese, James L.
Venue: Diabetes
Publisher: American Diabetes Association
Published: 2017-04-13
Volume: 66
Issue: 5
Pages: 1103-1110
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/db16-1477
PMC: PMC5399609
OpenAlex: W2615250694
Cited by: 516
References: 50
Citations by year: 2026: 43 · 2025: 55 · 2024: 78 · 2023: 71 · 2022: 79 · 2021: 61 · 2020: 59 · 2019: 40 · 2018: 24 · 2017: 5
FWCI: 15.43
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.diabetesjournals.org/content/license (vor, 7 d)
Locations: Diabetes (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
IUScholarWorks (Indiana University) (submittedVersion)
Funders: National Institutes of Health
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords: pancreatic ductal adenocarcinoma, type 2 diabetes, pancreatic diabetes, new-onset diabetes, pancreatic cancer risk factors, diabetes management, early cancer detection
MeSH terms: Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Inflammation, Obesity, Pancreatic Neoplasms, Risk Factors, Causality, Genetic Predisposition to Disease, Carcinoma, Pancreatic Ductal, Pancreatitis, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks